Clinical trial of a new bleeding-time device

Area of Science:

• Medical Devices
• Hematology
• Clinical Trials

Background:

• Bleeding time is a critical diagnostic parameter.
• Existing devices like the Mielke Template have limitations.
• A simpler, rapid bleeding time device is needed.

Purpose of the Study:

• To compare the performance of the Simplate II device against the Mielke Template.
• To evaluate the reproducibility and ease of use of the Simplate II.
• To assess bleeding times in healthy volunteers and patients.

Main Methods:

• A clinical trial involving 24 healthy volunteers and 28 patients.
• Simultaneous bleeding time measurements using Simplate II and Mielke Template on the same arm.
• Measurements taken before and after aspirin ingestion in healthy volunteers.
• Assessment of scarring and reproducibility.

Main Results:

• No significant differences in bleeding times between Simplate II and Mielke Template in normal subjects (pre- and post-aspirin) or patients.
• Mean pre-aspirin bleeding times: Simplate II (4.75 ± 1.42 min) vs. Mielke Template (3.65 ± 1.22 min).
• Mean post-aspirin bleeding times: Simplate II (7.86 ± 2.76 min) vs. Mielke Template (7.84 ± 2.94 min).
• Similar scarring extent and high reproducibility for both devices.
• Simplate II was simpler and faster to use.

Conclusions:

• The Simplate II device is a reliable alternative to the Mielke Template for measuring bleeding time.
• The new device offers advantages in terms of simplicity and speed.
• Clinical trials confirm the efficacy and reproducibility of Simplate II.